Anthos Therapeutics to Host Discussion with Global Experts o

Anthos Therapeutics to Host Discussion with Global Experts on the Promise of Factor XI Inhibition at the 2022 BIO International Convention

CAMBRIDGE, Mass., June 13, 2022 /PRNewswire/ -- Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for ca...

Related Keywords

United States , Tennessee , United Kingdom , Israel , Texas , Decatur , Massachusetts , Tel Aviv , Cambridge , Cambridgeshire , London , City Of , Vanderbilt University , American , Ajay Kakkar , R John Glasspool , David Gailani , John Glasspool , Coll Cardiol , Medicina Chirurgia , Ernestw Goodpasture , Ophira Salomon , Olipriya Das , Tony Russo , Thromb Haemost , King College London , American Heart Association , Linkedin , Twitter , American Foundation For Women Health , Sheba Medical Center , Russo Partners , San Diego Convention Center , Novartis , Companies Section , Washington University , Clinical Coagulation Laboratory At Vanderbilt University Hospital , Imperial College London , Professor In Hematology At Tel Aviv University , Dalcor Corporation , Experimental Pathology For Translational Research , University Of Illinois College Medicine , National Afib Health Policy Roundtable , International Convention , Research Institute Of Thrombosis Hemostasis , Thrombosis Research Institute , Tel Aviv University , Royal College Of Surgeons , Blackstone Life Sciences , New England Journal , Exploring Factor , Paradigm Shift , Hemostasis Sparing Anticoagulant , Session Room , Upper Level , San Diego Convention , Lord Kakkar , True Hills , American Foundation , Chief Executive Officer , Mellanie True Hills , College London , Imperial College , Royal College , Associate Professor , Research Institute , Sheba Medical , Experimental Pathology , Illinois College , Clinical Coagulation Laboratory , Vanderbilt University Hospital , Certified Speaking Professional , Afib Awareness Month , Atrial Fibrillation Patient , Session Moderator , Relmada Therapeutics Inc , Anthos Therapeutics , Global Head , Metabolic Diseases , Region Head , Market Access , Englj Med July , Private Securities Litigation Reform Act ,

© 2025 Vimarsana